Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

Solara announces leadership succession plan

Posted On: 2019-12-09 11:44:02


Solara Active Pharma Sciences Limited (Solara), one of India's leading pureplay active pharmaceutical ingredients Company today announces the appointment of Bharath R. Sesha (Bharath) as the new Chief Executive Officer (CEO) to succeed Jitesh Devendra (Jitesh), the incumbent CEO and Managing Director of the Company.

In April 2017, Jitesh was selected by the Board to take over as the CEO and Managing Director of Solara, a company that was built on the carved API businesses of Strides Pharma Science Limited (Formerly Strides Shasun Limited) and Sequent Scientific Limited to embark on the path to become a compelling global standalone API player. Solara, since then, has come off a long way to establish a niche for itself in the global pure-play active pharmaceutical business.

At the time of Jitesh's appointment with the Company, he was expected to lead Solara until such time the Company attains a critical size which would then allow Jitesh to pursue his interests outside of Solara which he had planned before agreeing to his role. The Board is pleased with Jitesh's contributions that have resulted in Solara achieving all the intended strategic outcomes under his leadership. Consequently, the Board has agreed to a planned separation with Jitesh and is thankful to him for transitioning his role to Bharath, an equally astute leader to take over the helm of affairs at Solara.

Bharath joins Solara from Nalco Water, India where he was the Managing Director responsible for the growth strategy. He has over two decades of experience and a decade leading diverse businesses including pharmaceuticals and has held CXO level positions in companies like Philips, DSM Sinochem Pharmaceuticals, Royal DSM NV. Throughout his professional stints, Bharath has focused on managing the business growth and profitability of these companies across the pharmaceutical, healthcare, consumer lifestyle, and material sciences industries. He has operated in countries like USA, Hongkong, China, Middle East, Egypt, Africa and Europe. Bharath is an Engineering graduate with a management degree from the Institute for Technology and Management, Chennai. He also has a master's degree in International Management from Thunderbird School of Global Management, United States.

Commenting on the development, Deepak Vaidya, Chairman of the Board said: "The Board would like to thank Jitesh for his strong leadership at Solara. Under Jitesh, the Company achieved new heights from where it started, and today, it is on a growth trajectory to take on the future opportunities in this growing API industry. As part of the succession plan, the Board is pleased to announce Bharath as the Company's new CEO who brings his significant strategic experience from his extensive career across multiple companies to deliver on the Company's value creation strategy. Jitesh will continue to be on the Board as the Managing Director for about a year and will continue to play a guiding role for the company in this transitionary phase."

Jitesh, the Outgoing CEO, remarked: "I had the pleasure of leading this young company and be part of this exciting and extraordinary journey. I must take the opportunity to thank the founders and the Board members who reposed their trust in me and extended their full support in building Solara to what it has attained today. I am also grateful to the passion and hard work of my team at Solara, who helped me achieve all possible outcomes with their selfless commitment. Personally, this has been a very emotional decision, and I feel it is tough for me to disengage from a company I have been involved since its inception. That said, I continue to be positive on the future of Solara, and I genuinely believe that Solara gets an exceptionally talented leader in Bharath. I will continue to support Bharath in effecting a seamless transition of my role."

Bharath, the new CEO designate, commented: "I am delighted to be joining Solara as its CEO, and I am grateful to the Board for offering me this opportunity. Certainly, these are exciting times for the industry, and I hope we will continue to create new opportunities for growth in our business to drive significant value for all the stakeholders. As the CEO, I am looking forward to working with an exceptional group of people over the coming years to carry our legacy forward. I would also like to extend my gratitude to Jitesh for his remarkable leadership at Solara and to extend his time and work jointly with me over the next year."

Shares of Solara Active Pharma Sciences Ltd was last trading in BSE at Rs.443.3 as compared to the previous close of Rs. 444.5. The total number of shares traded during the day was 707 in over 146 trades.

The stock hit an intraday high of Rs. 447.4 and intraday low of 443. The net turnover during the day was Rs. 314030.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Paushak Limited receives approval for expanding production capacity of Phosgene to 14,400 MTPA

Thomas Cook (India) Limited announces results for Q1 FY21

Info Edge India Ltd fixes floor price of QIP as Rs. 3177.18

LIC ups stake in YES Bank to 4.989% through market purchase

Persistent Receives 2020 Workato Partner Award for Innovation

Infosys USA certified as Great Place To Work®

Eris Lifesciences Ltd Board declares Interim Dividend of Rs. 5.50

Thomas Cook India Ltd Q1FY21 consolidated loss at Rs. 94.20 crore

PTC India Financial Services Ltd posts consolidated PAT of Rs. 26.56 crore

Sun Pharma Advanced Research Company Ltd Q1FY21 PAT at Rs. 56.69 crore

MRPL Q1 consolidated loss at Rs. 719.78 crore

ITC's Paperboards Unit at Bhadrachalam conferred with GreenCo Platinum+ rating by CII Green Business Centre for its Environmental Stewardship

NMDC registers record jump in production and sales of iron ore in July 2020

Titan Eyeplus in association with Sankara Nethralaya, Chennai launches Teleconsultation Eye care Services for its customers across the country

JSPL Felicitates its COVID-19 warriors

IndiGo repatriated 212 Indians citizens from Russia

Axis Bank Limited announces opening of QIP, floor price fixed as Rs. 442.19

Narayana Hrudalaya Ltd Q1 FY21 Consolidated operating income at Rs 3,935 mn

Tata Consumer Products Ltd announces results for the quarter ended 30th June 2020

Geojit Announces Appointment of Alice G. Vaidyan to the Board

Maruti Suzuki - Delivering sustainable growth through inclusive approach

ASM Technologies Ltd Board recommends interim dividend of Rs. 2

Digitate Launches ignio™ AI.Assurance to Transform Software Testing and Speed Up Software Release Cycles

Lupin Receives Tentative Approval for Empagliflozin Tablets

Sun Pharma launches FluGuard® (Favipiravir) in India at Rs. 35 per tablet

PI Industries Ltd posts consolidated net profit of Rs. 145.5 crore

Tata Consumer Products Ltd Q1FY20 consolidated PAT surges to Rs. 327.56 crore

Zim Laboratories Ltd Q1 consolidated PAT soars to Rs. 3.28 crore

Uniphos Enterprises Ltd posts Rs. 0.25 crore PAT in Q1FY21

Jenburkt Pharmaceuticals Ltd Q1 PAT at Rs. 1 crore

Gujarat Gas Ltd reports Rs. 59.07 crore consolidated PAT in Q1FY21

Unichem Laboratories Ltd Q1FY21 consolidated net profit at Rs. 2.43 crore

Astral Poly Technik Ltd Q1FY21 consolidated PAT falls

Tamilnadu Petroproducts Ltd Q1 consolidated PAT rises QoQ, drops YoY

Geojit Financial Services Ltd Q1FY21 consolidated net profit jumps to Rs. 23.84 crore

Century Enka Ltd posts Rs. 24.90 crore loss in Q1FY21

Vinyl Chemicals India Ltd reports higher net profit of Rs. 1.16 crore in Q1FY21

Bhansali Engineering Polymers Ltd Q1 consolidated loss at Rs. 1.38 crore

Gujarat Sidhee Cement Ltd reports Rs. 4.98 crore consolidated PAT in Q1

Atishay Ltd posts Q1FY21 net profit of Rs. 0.58 crore

Godrej Consumer Products Ltd Q1FY21 consolidated PAT rises QoQ basis

ASM Technologies Ltd Q1FY21 consolidated PAT at Rs. 3.70 crore

Igarashi Motors India Ltd Q1FY21 loss at Rs. 10.52 crore

HIKAL Ltd Q1FY21 consolidated PAT at Rs. 15 crore

Varun Beverages Ltd Board declares Interim Dividend of Rs. 2.50 for CY2020

Deccan Cements Ltd board to announce Q1 results on Aug 14, 2020

Berger Paints India Ltd board to approve quarterly results on Aug 14, 2020

Marksans Pharma Ltd Q1FY21 Revenue at Rs. 331.3 Cr

Ashok Leyland subsidiary Optare delivers first of 21 battery-electric Metrodecker EV with First York

Ashwini Kumar Tewari Takes Charge as The Managing Director and CEO of SBI Card







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019